Cargando…
Cost-effectiveness of cervical cancer screening with primary HPV testing for unvaccinated women in Sweden
BACKGROUND: Sweden revised their cervical cancer screening program in 2017 to include cytology-based screening for women aged 23–29 years and primary human papillomavirus (HPV) testing for women aged 30–64 years; however, alternative strategies may be preferred. To inform cervical cancer prevention...
Autores principales: | Fogelberg, Sara, Clements, Mark S., Pedersen, Kine, Sy, Stephen, Sparén, Pär, Kim, Jane J., Burger, Emily A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526933/ https://www.ncbi.nlm.nih.gov/pubmed/32997696 http://dx.doi.org/10.1371/journal.pone.0239611 |
Ejemplares similares
-
Opportunistic HPV vaccination at age 16–23 and cervical screening attendance in Sweden: a national register-based cohort study
por: Kreusch, Teresa, et al.
Publicado: (2018) -
Cervical cancer screening in Sweden 2014-2016
por: Hortlund, Maria, et al.
Publicado: (2018) -
When Life Got in the Way: How Danish and Norwegian Immigrant Women in Sweden Reason about Cervical Screening and Why They Postpone Attendance
por: Azerkan, Fatima, et al.
Publicado: (2015) -
Impact of HPV vaccination on cervical screening performance: a population-based cohort study
por: Lei, Jiayao, et al.
Publicado: (2020) -
Choosing wisely: a model-based analysis evaluating the trade-offs in cancer benefit and diagnostic referrals among alternative HPV testing strategies in Norway
por: Burger, Emily A, et al.
Publicado: (2017)